Cancer and Molecular Therapies

Dr. Yaron Carmi

Cancer immunotherapy

Our body's immune system know s how to attack and kill cancer cells – so why isn’t this happening in each case? How do we unblock this natural lethal response?

Dr Carmi is taking a fresh approach to the problem using advanced microscopy and genetic engineering to monitor, in real time, how our immune cells communicate with each other. He will use the new understanding to develop better, safer therapies that kick in the natural anti-cancer immune response .

Dr. Carmi, Department of Pathology, completed his PhD studies summa cum laude at Ben -Gurion University of the Negev and won the Pratt award for excellence PhD students. He completed his postdoctoral training at the Department of Immunology at Stanford University, where he earned the Young Investigator Award . His work on dendritic cell vaccination was published in Nature and Cell and he has co -authored manuscripts in peer-reviewed journals, including Science and Immunity, and written four patents. Based on his findings, he co -founded two companies, Bolt Therapeutics and more recently, Gilboa Therapeutics, and he serves as a consultant in Velocity Pharmaceutical Development venture capital, and as a board member at the Israel Society for Gene and Cell Therapy. Carmi was awarded the Alon Fellowship for outstanding young Israeli scientists.

https://www.carmilab.org/

NK cells attacking a tumor cell